How Insurance Companies Turn Their Premiums Into Billions in Profit
There’s a timing mismatch in the insurance industry that is very profitable for shareholders.
How Safe is Bristol Myers Squibb’s Dividend? Here’s My Honest Take.
Bristol Myers Squibb has a well-above-market yield of 4.5% and it appears reasonably safe.
Is Palantir Stock Ripe for a Rebound?
The once high-flying stock has declined 26% so far this year.
Micron Reports Earnings June 24. Here’s the One Number That May Make or Break the Stock.
One figure from the memory maker’s upcoming report matters more than the rest — and it will likely set the tone for the stock.
These Are the Only 2 Cryptocurrencies I’m Comfortable Buying Right Now
The crypto market’s pullback is revealing that many valuations were based solely on hot air.
SpaceX Is Worth $2.1 Trillion on Its First Day of Trading. Is That a Problem for Investors?
The SpaceX IPO is finally over, and the company is already one of the largest in the world.
Fintech Stock Block Is Trying to Prove That the Ultimate Cryptocurrency Has a Real Use Case, But Will It Work?
The innovative financial services and payments enterprise continues to operate with a forward-looking attitude.
Down 50% Over the Past Year, Is There Anything Adobe Can Do to Rebound?
The stock has struggled despite the company’s consistency.
Huge News for GM Stock, Tesla Stock, and Ford Stock Investors
Competition is increasing in the battery storage business.
Why Is Adobe Stock Crashing, and is it a Buying Opportunity?
Investors focused on the CFO’s resignation, sending the share price even lower.
What’s Going on With Marvell Stock?
The semiconductor design company is forecasting strong growth for several years.
Should You Buy Zeta Global Stock on the Dip?
Investors want to know if this is a buying opportunity or a falling knife to avoid.